A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications
It is called microdosing GLP-1s, and for many it feels like the only answer to a desperate problem
Collected variables The following data were collected at baseline, and at the 6- and 12-month follow-up visits: anthropometric parameters, namely, weight, body mass index (BMI), waist circumference, and blood pressure
Why "Short-Term" Is Written Into the Indication Phentermine is a Schedule IV controlled substance
Although research has examined daily doses ranging from 250 mg to 1,000 mg in healthy adults, the optimal amount may vary depending on individual health status, needs, and underlying conditions
The subjects treated with tirzepatide lost 21.4% of their body weight, on average, over 12 months, equating to 49.4lb (22.4kg)